Annual Statements Open main menu

NOTOX TECHNOLOGIES CORP. - Quarter Report: 2016 May (Form 10-Q)

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended May 31, 2016

 

or

 

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______________ to________________

 

Commission file number 001-34911

 

  TROPIC INTERNATIONAL INC.  

(Exact name of registrant as specified in its charter)

 

Nevada   None

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

     
1057 Parkinson Road, Unit #9    
Woodstock, Ontario, Canada   N4S 7W3
(Address of principal executive offices)   (Zip Code)

 

  (519) 421-1900  

(Registrant’s telephone number, including area code)

 

N/A

(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [  ]

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [  ] No [  ]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer [  ]   Accelerated filer [  ]
Non-accelerated filer [  ]   Smaller reporting company [X]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [  ] No [X]

 

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PRECEDING FIVE YEARS:

 

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yes [  ] No [  ]

 

APPLICABLE ONLY TO CORPORATE ISSURS:

 

As of July 15, 2016, the registrant’s outstanding common stock consisted of 112,264,146 shares.

 

 

 

 

 

 

TABLE OF CONTENTS

 

PART I – FINANCIAL INFORMATION  
  3
Item 1. Financial Statements 5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 9
Item 3. Quantitative and Qualitative Disclosures about Market Risk 9
Item 4. Controls and Procedures 9 
 
PART II – OTHER INFORMATION  
  11
Item 1. Legal Proceedings 11
Item 1A. Risk Factors 11
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 11
Item 3. Defaults Upon Senior Securities 11
Item 4. Mine Safety Disclosures 11
Item 5. Other Information 11
Item 6. Exhibits 11
  13
SIGNATURES  

 

2 
 

 

PART I – FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

Tropic International Inc.

Consolidated Financial Statements
For the Nine Months Ended May 31, 2016

(Expressed in Canadian dollars)

(unaudited)

 

  Index
   
Consolidated Balance Sheets F-1
   
Consolidated Statements of Loss and Comprehensive Loss F-2
   
Consolidated Statements of Cash Flows F-3
   
Consolidated Statements of Stockholders’ Equity F-4
   
Notes to the Consolidated Financial Statements F-5

 

3 
 

 

TROPIC INTERNATIONAL INC.

CONSOLIDATED BALANCE SHEETS

(EXPRESSED IN CANADIAN DOLLARS)

(UNAUDITED)

 

  

May 31, 2016

  

August 31, 2015

 
   (Unaudited)     
ASSETS          
Current assets:          
Cash  $25,982   $8,336 
Amounts receivable   9,697    3,681 
Inventory   124,665    130,702 
Prepaid expenses   3,300    3,300 
Total current assets   163,644    146,019 
Equipment, net (Note 6)   45,419    53,434 
Intangible assets, net (Note 7)   3,846,267    4,121,771 
Total assets  $4,055,330   $4,321,224 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current liabilities:          
Accounts payable and accrued liabilities (Notes 8 and 9)  $586,699   $292,390 
Advances from shareholders (Notes 9 and 10)   439,471    425,175 
Total current liabilities   1,026,170    717,565 
           
Stockholders’ equity (Note 12):          
Common stock   12,612    12,612 
Stock subscribed   179,991    30,000 
Additional paid-in capital   8,431,728    8,431,728 
Deficit   (5,595,171)   (4,870,681)
Total stockholders’ equity   3,029,160    3,603,659 
Total liabilities and stockholders’ equity  $4,055,330   $4,321,224 

  

Contingent liability (Note 15)

 

See accompanying notes to the consolidated financial statements.

 

F-1
 

 

TROPIC INTERNATIONAL INC.

CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS

(EXPRESSED IN CANADIAN DOLLARS)

(UNAUDITED)

 

   For the Nine Months Ended 
  

May 31, 2016

  

May 31, 2015

 
Revenue:          
 Sales  $863   $3,626 
           
Production costs:          
 Amortization - patent   280,453    279,806 
 Consulting fees – production   23,400    23,400 
Depreciation   8,015    10,019 
Materials and supplies   7,725    12,382 
Writedown of inventory   365    529 
Total production costs   319,958    326,136 
Gross loss   (319,095)   (322,510)
           
General and administration:          
Consulting fees – management (Note 9)   283,806    138,814 
 Depreciation   -    4,331 
Interest on advances from shareholders (Notes 9 and 10)   9,296    8,537 
Loss on foreign exchange   2,089    4,123 
Marketing   8,327    12,417 
Office and miscellaneous   16,883    17,995 
Professional fees   56,928    39,141 
Rent   9,900    9,900 
Travel and entertainment   9,250    7,349 
Trust and filing fees   2,122    - 
Total general and administration   398,601    242,607 
Loss before other item and income taxes   (717,696)   (565,117)
Other item:          
Writedown of patent costs (Note 7)   (6,794)   - 
Loss before income taxes   (724,490)   (565,117)
Income taxes   -    - 
Net loss and comprehensive loss  $(724,490)  $(565,117)
           
Net loss per share – basic and diluted (Note 4)  $(0.06)  $(0.05)
           
Weighted-average number of shares outstanding   12,264,146    12,264,146 

 

See accompanying notes to the consolidated financial statements.

 

F-2
 

 

TROPIC INTERNATIONAL INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(EXPRESSED IN CANADIAN DOLLARS)

(UNAUDITED)

 

   For the Nine Months Ended 
  

May 31, 2016

  

May 31, 2015

 
         

Cash Flows To Operating Activities

          
Net loss  $(724,490)  $(565,117)
Adjustments to reconcile net loss to net cash provided by operating activities:          
Amortization – patent   280,543    279,806 
Depreciation   8,015    14,350 
Writedown of inventory   365    529 
Writedown of patent costs   6,794    - 
Changes in assets and liabilities:          
Amounts receivable   (6,016)   (14,013)
Inventory   5,672    9,568 
Prepaid expenses   -    (1,200)
Accounts payable and accrued liabilities   294,309    148,808 
Interest accrued on advances from shareholders   9,296    8,537 
Net cash used in operating activities   (125,602)   (118,732)
           

Cash Flows To Investing Activities

          
Patent costs   (11,743)   (6,037)
Net cash used in investing activities   (11,743)   (6,037)
           
Cash Flows From Financing Activities          
Advances from shareholders   5,000    102,500 
Stock subscriptions received   149,991    15,000 
Net cash provided by financing activities   154,991    117,500 
           
Increase (decrease) in cash during the period   17,646    (7,269)
Cash, beginning of period   8,336    18,018 
Cash, end of period  $25,982   $10,749 

 

See accompanying notes to the consolidated financial statements.

 

F-3
 

 

TROPIC INTERNATIONAL INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(EXPRESSED IN CANADIAN DOLLARS)

(UNAUDITED)

 

  

Common Stock

                 
   *   Shares   Amount   Stock subscribed   Additional
paid-in
capital
   Deficit  

Total

stockholders’ equity

 
Balance at August 31, 2012   56,516,523   $7,932,201   $-   $-   $(2,488,050)  $5,444,151 
Shares issued for cash   10,890,100    552,000    -    -    -    552,000 
 Shares issued in exchange for management services   32,593,377    16,297    -    -    -    16,297 
Recapitalization on reverse takeover
(see Notes 2 and 12):
   -    (8,487,886)   -    8,431,728    -    (56,158)
Elimination of issued share capital of TSI   (100,000,000)   -    -    -    -    - 
Establishment of issued share capital of RMI   12,264,146    -    -    -    -    - 
 Net loss   -    -    -    -    (781,639)   (781,639)
Balance at August 31, 2013   12,264,146    12,612    -    8,431,728    (3,269,689)   5,174,651 
Net loss   -    -    -    -    (826,366)   (826,366)
Balance at August 31, 2014   12,264,146    12,612    -    8,431,728    (4,096,055)   4,348,285 
Net loss   -    -    -    -    (774,626)   (774,626)
Shares subscribed   -    -    30,000    -    -    30,000 
Balance at August 31, 2015   12,264,146    12,612    30,000    8,431,728    (4,870,681)   3,603,659 
Net loss   -    -    -    -    (724,490)   (724,490)
Shares subscribed   -    -    149,991    -    -    149,991 
Balance at May 31, 2016   12,264,146   $12,612   $179,991   $8,431,728   $(5,595,171)  $3,029,160 

 

*The above presentation reflects the issued share capital of TSI until the completion of the capital transaction, at which point it is adjusted to reflect the share capital of the legal parent company RMI.

 

See accompanying notes to the consolidated financial statements.

 

F-4
 

 

TROPIC INTERNATIONAL INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(EXPRESSED IN CANADIAN DOLLARS)

(UNAUDITED)

 

1. Company Overview and Basis of Presentation

 

Nature and History of Operations

 

Tropic International, Inc. (formerly Rockford Minerals, Inc.) (the “Company”) was incorporated under the laws of the state of Nevada on October 29, 2007. The Company was a natural resource exploration company with an objective of acquiring, exploring and, if warranted and feasible, developing natural resource properties. Activities during the exploration stage included developing the business plan and raising capital.

 

On June 28, 2013, the Company completed a reverse takeover transaction (see Note 2) with Tropic Spa Inc. (“TSI”), a company that manufactures and sells Home Mist Tanning units that deliver a full-body application. As a result of this transaction, the Company became a holding company operating through TSI. Upon the closing of the share exchange agreement described below, the Company changed its fiscal year end from October 31 to August 31 to coincide with the fiscal year end of TSI.

 

On December 6, 2013, the Company changed its name to Tropic International Inc. as a result of a merger with Tropic International Inc., a wholly-owned subsidiary incorporated solely to effect the name change. The accompanying consolidated financial statements include the results of operations of TSI and the Company for the nine month periods ended May 31, 2016 and 2015.

 

On September 3, 2014, the Company’s shares became eligible for quotation on the OTCQB under the symbol TRPO.

 

On November 19, 2007, TSI entered into Share Subscription Agreements (the “Agreements”) with MCM Consulting Ltd., Nandoor Enterprises Ltd., Sierra Tan Ltd., Sunshower Incorporated, Sunshower International Corporation and Tropic Spa Group Inc. (the “Originating Companies”). Pursuant to the terms of the Agreements, the Originating Companies subscribed for, in aggregate, 18,202,503 common shares of TSI valued at $3,657,175. This assigned value was the cost to the Originating Companies, as of that date, of developing a Home Mist Tanning system and the application for and acquisition of a United States Patent “Apparatus for Spray Application of a Sunless Tanning Product” (the “US Patent”). The Agreements included a triggering event (a “Triggering Event”) which was defined to mean the occurrence of any of the following events:

 

  Ninety days after TSI has been listed as a public company on a stock exchange;
     
  Ninety days after TSI either purchases or is purchased by a company that is trading on a stock exchange; or
     
  Notwithstanding the above, ninety days after TSI has notified the Originating Companies in writing that a Triggering Event has occurred.

 

The Originating Companies entered into agreements with their shareholders allowing the shareholders, upon the Triggering Event, to exchange their class A shares in the Originating Companies, by exercising the option under their common share exchange warrant, for common shares in TSI.

 

On April 9, 2009, the Board of Directors of TSI (the “Board”) resolved that the Triggering Event had occurred and approved and issued a Notification of Triggering Event to the shareholders of the Originating Companies. The decision to exercise the Triggering Event was driven by three factors:

 

  The approval of the US Patent;
     
  Delivery of the final production model on or before April 21, 2009; and
     
  Implementation of an aggressive marketing strategy.

 

F-5
 

 

TROPIC INTERNATIONAL INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(EXPRESSED IN CANADIAN DOLLARS)

(UNAUDITED)

 

1. Company Overview and Basis of Presentation (cont’d)

 

After November 19, 2007, and subsequent to the execution of the Agreements, Tropic Spa Group Inc. (“TSGI”) incurred an additional $2,685,104 on the continued development of the Home Mist Tanning system and the application for and acquisition of the US Patent. On March 11, 2013, TSI executed a second Share Subscription Agreement (the “Second Agreement”) with TSGI to cover the common shares of TSI issued to the shareholders of TSGI in respect of the additional costs incurred. Pursuant to the terms of the Second Agreement, TSGI subscribed for 26,034,520 common shares valued at $3,155,462 covering the period from November 20, 2007 to June 2010. Of these amounts, 3,880,745 common shares are for $470,358 received directly by TSI. The value assigned to the carrying value of the US Patent, during the year ended August 31, 2010, was $2,685,104 ($3,155,462 less $470,358). The total value assigned to the carrying value of the US Patent pursuant to the Agreements and the Second Agreement, collectively, was $6,342,279.

 

On October 16, 2014, the Company, through TSI, obtained an Australian patent (“Australian Patent”), incurring application costs of $4,975.

 

The Company, through TSI, has patents pending which are in the process of being completed for Canada and China. Costs incurred are recorded as intangible assets (see Note 7).

 

As reflected in the accompanying consolidated financial statements, the Company has a deficit of $5,595,171 (August 31, 2015 - $4,870,681) since inception, a working capital deficiency of $862,526 (August 31, 2015 - $571,546) and stockholders’ equity of $3,029,160 (August 31, 2015 - $3,603,659). This raises substantial doubt about its ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on its ability to raise additional capital and to implement its business plan. The accompanying consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Management believes that actions presently being taken to obtain additional funding and implement its strategic plans provide the opportunity for the Company to continue as a going concern.

 

2. Reverse Takeover

 

On June 28, 2013 (the “Closing Date”), the Company, its wholly-owned subsidiary 1894632 Ontario Inc. (“Subco”) and TSI entered into a share exchange agreement (the “Exchange Agreement”) with certain of the shareholders of TSI (the “Selling Shareholders”) pursuant to which the Company acquired 78,030,877 common shares, or approximately 78% of the issued and outstanding shares, of TSI in exchange for the issuance of 78,030,877 preferred shares of Subco to the Selling Shareholders on a one-for-one basis. Each one preferred share of Subco is exchangeable into one share of the Company’s common stock at the option of the holder subject to the following restrictions:

 

  The Selling Shareholders require the written consent of Subco to exchange, sell or otherwise dispose of, directly or indirectly, any of their preferred shares of Subco until the six month anniversary of the Closing Date;
     
  Within 30 days of that time, and provided TSI has generated at least $1,000,000 in gross revenue during the preceding six month period, Subco shall permit the Selling Shareholders to require Subco to redeem an aggregate of 1% of its then-outstanding preferred shares on a pro-rata basis; and
     
  Within 30 days of each six month anniversary of the Closing Date until June 30, 2017, on which date all restrictions on the preferred shares shall automatically expire unless extended by the Selling Shareholders, Subco shall grant the holders of its preferred shares a permission identical to the one above.

 

F-6
 

 

TROPIC INTERNATIONAL INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(EXPRESSED IN CANADIAN DOLLARS)

(UNAUDITED)

 

2. Reverse Takeover (cont’d)

 

Upon completion of the Exchange Agreement, the sole officer and director of TSI became the sole officer and a director of the Company and the Company adopted the business plan of TSI.

 

As a result of the share exchange, the former shareholders of TSI control approximately 87% of the issued and outstanding common shares of the Company. The Exchange Agreement is a reverse takeover and therefore has been accounted for under the acquisition method with TSI as the accounting acquirer and continuing entity for accounting and financial reporting purposes and the Company as the legal parent being the acquiree. The business is in the development stage and there was no active market to reliably determine fair value of the consideration other than the value of the identifiable assets acquired.

 

Therefore, the purchase price allocation of the acquisition was based on the fair value of the net liabilities acquired which was charged to additional paid-in-capital.

 

The fair values of assets acquired and liabilities assumed are as follows:

 

Cash  $1,774 
Subscriptions receivable   10 
Accounts payable and accrued liabilities   (32,488)
Loan payable to TSI   (25,454)
Net liabilities acquired  $(56,158)

 

On February 17, 2015, the Company, Subco, TSI and the Selling Shareholders entered into an amendment to the Exchange Agreement in order to correct certain administrative errors in the Exchange Agreement and provide for the post-closing execution of the Exchange Agreement by those shareholders of TSI who were not original signatories thereto. In addition, the Selling Shareholders approved certain changes to the rights, privileges, restrictions and conditions attached to the preferred shares of Subco by consent in writing. This included extending the automatic expiration date in respect of the preferred shares of Subco from June 30, 2015 to June 30, 2017.

 

3. Summary of Significant Accounting Policies

 

Principles of Consolidation

 

The accompanying consolidated financial statements include the financial statements of the Company, TSI, Subco and 1894631 Ontario Inc., the Company’s wholly-owned subsidiary. All significant inter-company balances and transactions have been eliminated.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. On an ongoing basis, the Company evaluates its estimates, including those related to equipment, fair values of intangible assets, and useful lives of intangible assets and the likelihood of realization of its deferred tax assets. The Company bases its estimates on assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.

 

F-7
 

 

TROPIC INTERNATIONAL INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(EXPRESSED IN CANADIAN DOLLARS)

(UNAUDITED)

 

3. Summary of Significant Accounting Policies (cont’d)

 

Concentration of Risk

 

The financial instrument which potentially subjects the Company to a concentration of credit risk is cash. The Company places its cash in an account with a high credit quality financial institution.

 

Significant Accounting Policies

 

The accompanying consolidated financial statements reflect the application of certain significant accounting policies. There have been no material changes to the Company’s significant accounting policies that are disclosed in the consolidated financial statements and notes thereto during the period ended February 29, 2016.

 

Inventory

 

Inventory is stated at the lower of cost, computed using the first-in, first-out method, or market. If the cost of inventory exceeds its market value, a provision is made currently for the difference between the cost and market value. The Company’s inventory consists of finished goods, components and supplies.

 

Equipment, Net

 

Equipment is stated at cost, net of accumulated depreciation. Equipment is depreciated over the estimated useful life of the asset. Mould equipment is depreciated at 20% on a declining-balance basis. The website is depreciated on a straight-line basis over five years. One-half of these rates are used in the year of acquisition. Replacements and major improvements are capitalized, while maintenance and repairs are charged to expense as incurred. Upon retirement or sale, the cost of assets disposed of and related accumulated depreciation are removed from the accounts, and any resulting gain or loss is credited or charged to operations.

 

Intangible Assets

 

The US Patent is recorded at the value attributed to the shares issued to the Originating Companies and shareholders of TGSI less accumulated amortization. The US Patent was issued on September 29, 2009 and is effective until September 29, 2026. The Australian Patent is recorded at the application costs incurred less accumulated amortization. The Australian Patent was issued on October 16, 2014 and is effective until April 5, 2027. Upon expiration, the patents can be extended subject to certain changes required to secure the extension. Although the effects of obsolescence, demand, competition and other economic factors (such as stability of the industry, technological advances and legislative action that results in an uncertain or changing regulatory environment) can have an adverse effect on the industry and the Company’s product, management is not currently aware of any known adverse factors that will affect the Company in the future.

 

Costs incurred for patents which are in the process of being completed will be amortized over the life of the patent when the patent is issued.

 

The Company does not believe that there are any limits to how long its Home Mist Tanning units can sell in the market place. While it expects to be able to secure extensions for its patents prior to expiry, this cannot be predicted with certainty at this time. Accordingly, management has determined that the best estimate of the useful life of the US Patent is 17 years and the Australian Patent is 13 years. At this time, the Company does not believe that the patents will have a residual value at the end of their useful lives.

 

Definite-lived intangible assets are required to be amortized using a method that reflects the pattern in which the economic benefits of the patents are consumed or utilized. At this time, management is not able to determine with any amount of certainty the number of Home Mist Tanning units that will be sold over the useful lives of the patents. Accordingly, the patents are being amortized on a straight-line basis over the period of their useful lives.

 

F-8
 

 

TROPIC INTERNATIONAL INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(EXPRESSED IN CANADIAN DOLLARS)

(UNAUDITED)

 

3. Summary of Significant Accounting Policies (cont’d)

 

Intangible assets subject to amortization are required to be reviewed for impairment. An impairment loss must be recognized if the intangible asset’s carrying amount is not recoverable and the carrying amount exceeds fair value. The Company applies the following three-step process to identify, recognize and measure impairment of the patents:

 

  Consider whether indicators of impairment are present indicating that the patent’s carrying amount might not be recoverable;
     
  If indicators are present, perform a recoverability test by comparing the sum of the estimated undiscounted future cash flows attributable to the patent to its carrying amount; and
     
  If the undiscounted cash flows used in the recoverability test are less than the patent’s carrying amount, determine the patent’s fair value and recognize an impairment loss if the carrying amount exceeds fair value.

 

Because of the unique nature of a patent, an income-producing definite-lived intangible asset, the calculation of cash flows can be very difficult to estimate. In this case, the estimated cash flows reflect the direct revenue expected to be generated by the patent as well as an allocation of expenses.

 

Leases

 

The Company currently rents premises pursuant to an operating lease.

 

Impairment of Long-Lived Assets

 

Long-lived assets, including equipment and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount should be evaluated. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to the estimated undiscounted future cash flows expected to be generated by it. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds its fair value.

 

Sales and Other Revenue

 

The Company sells Home Mist Tanning units and related supplies primarily on line via its website. The Company recognizes revenue when the units and supplies have been shipped to the customer, the amount to be paid by the customer is fixed or determinable and collectability is reasonably assured. Revenue is recorded net of applicable sales taxes.

 

Warranty

 

The Company is committed to supplying products of superior quality and design. Because of this commitment, it provides a limited one year warranty effective from the date of purchase. The Company warranties its Home Mist Tanning units to be free of defects. If a unit stops operating due to defects in materials or workmanship, the Company either repairs or replaces it for free.

 

Production Costs

 

Production costs consist of patent amortization, production consulting fees, equipment depreciation, materials and supplies.

 

F-9
 

 

TROPIC INTERNATIONAL INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(EXPRESSED IN CANADIAN DOLLARS)

(UNAUDITED)

 

3. Summary of Significant Accounting Policies (cont’d)

 

Advertising Costs

 

The Company charges all advertising and marketing costs to expense in the period incurred.

 

Income Taxes

 

Deferred income tax is accounted for using the asset and liability method. Deferred income taxes are provided for temporary differences in recognizing certain income and expense items for financial reporting purposes and tax reporting purposes. Such deferred income taxes primarily relate to the difference between the tax bases of assets and liabilities and their financial reporting amounts. Deferred tax assets and liabilities are measured by applying enacted statutory tax rates applicable to the future years in which deferred tax assets or liabilities are expected to be settled or realized. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversals of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. At this time, the Company is not able to project future taxable income over the periods in which the deferred tax assets are deductible and, accordingly, management is not able to determine if it is more likely than not that the Company will realize the benefits of these deductible differences.

 

Derivative Financial Instruments

 

The Company does not have any derivative financial assets or liabilities.

 

Fair Value of Financial Instruments

 

Fair values of cash, accounts payable and accrued liabilities, and advances from shareholders approximate fair value because of the short-term nature of these items. Amounts receivable consists primarily of Harmonized Sales Tax (“HST”) receivable from the Government of Canada. HST is not a financial instrument.

 

Foreign Currency

 

The functional currency of the Company and its subsidiaries is the Canadian dollar. The accompanying consolidated financial statements are presented in Canadian dollars.

 

Foreign currency transactions are translated into functional currency using the exchange rates prevailing at the date of the transaction. Foreign currency monetary items are translated at the period-end exchange rate. Non-monetary items measured at historical cost continue to be carried at the exchange rate at the date of the transaction. Exchange differences arising on the translation of monetary items or on settlement of monetary items are recognized in the loss in the period in which they arise.

 

F-10
 

 

TROPIC INTERNATIONAL INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(EXPRESSED IN CANADIAN DOLLARS)

(UNAUDITED)

 

4. Loss Per Share

 

The following table sets forth the computation of loss per share:

 

   For the Nine Months Ended May 31, 
   2016   2015 
Net loss per share:          
Net loss  $(724,490)  $(565,117)
Weighted-average shares outstanding:          
Common stock   12,264,146    12,264,146 
Number of shares used in per share computations   12,264,146    12,264,146 
Loss per share  $(0.06)  $(0.05)

 

5. Fair Value Measurements

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. There is a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:

 

Level 1 – Observable inputs such as quoted prices in active markets for identical assets or liabilities;

 

Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and

 

Level 3 – Unobservable inputs that are supported by little or no market activity, which require management judgment or estimation.

 

The Company measures its financial instruments at fair value.

 

The carrying value of cash deposits is a reasonable estimate of its fair value due to the short maturity of the financial instrument.

 

The Company does not have assets and liabilities that are measured at fair value on a recurring basis.

 

6. Equipment, Net

 

Equipment, at cost, consisted of:

 

   May 31, 2016   August 31, 2015 
Mould equipment  $155,300   $155,300 
Website   28,875    28,875 
Equipment at cost   184,175    184,175 
Accumulated depreciation   (138,756)   (130,741)
Equipment, net  $45,419   $53,434 

 

Depreciation was $8,015 and $14,350 for the nine month periods ended May 31, 2016 and 2015, respectively.

 

F-11
 

 

TROPIC INTERNATIONAL INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(EXPRESSED IN CANADIAN DOLLARS)

(UNAUDITED)

 

7. Intangible Assets, Net

 

The following tables provide information regarding the patents and patents pending:

 

   May 31, 2016 
   Gross carrying amount   Accumulated amortization   Writedowns  

 

Net carrying amount

 
United States Patent  $6,342,279   $2,518,256   $-   $3,824,023 
Australian Patent   4,975    647    -    4,328 
Patents pending   24,710    -    6,794    17,916 
   $6,371,964   $2,518,903   $6,794   $3,846,267 

 

   August 31, 2015 
  

Gross

carrying

amount

   Accumulated amortization  

 

Net carrying amount

 
United States Patent  $6,342,279   $2,238,450   $4,103,829 
Patents pending   17,942    -    17,942 
   $6,360,221   $2,238,450   $4,121,771 

 

Also see Note 1 Company Overview and Basis of Presentation.

 

During the period ended May 31, 2016, management identified the following indicators of impairment indicating that the patents’ carrying amounts might not be recoverable:

 

The inability to raise equity financing to implement its strategic plan; and
   
Operating and cash flow losses since the Company completed the development of the US Patent.

 

Management performed a recoverability test and determined that the estimated undiscounted future cash flows are greater than the patents’ carrying amounts and that, accordingly, there is no impairment.

 

As of May 31, 2016, amortization expense on intangible assets for the next five years was expected to be as follows:

 

    Amount 
Year ending:      
2016   $93,368 
2017    373,473 
2018    373,473 
2019    373,473 
2020    373,473 
Thereafter    2,241,091 
Total   $3,828,351 

 

F-12
 

 

TROPIC INTERNATIONAL INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(EXPRESSED IN CANADIAN DOLLARS)

(UNAUDITED)

 

8. Accounts Payable and Accrued Liabilities

 

Accounts payable and accrued liabilities consisted of:

 

     May 31, 2016   August 31, 2015 
Trade payables  $572,699   $279,890 
Vendor accruals   14,000    12,500 
Accounts payable and accrued liabilities  $586,699   $292,390 

 

9. Related Party Transactions

 

The President of the Company advanced $5,000 during the nine months ended May 31, 2016 (2015 - $7,500) and $7,500 to the Company during the year ended August 31, 2015 (2014 - $245,000). Advances payable to the President totaled $257,500 at May 31, 2016 (2015 - $252,500) and $252,500 at August 31, 2015 (2014 - $245,000). These advances are unsecured and bear interest at 3% per annum. Of this amount, $245,000 is due on demand and $12,500 has no repayment terms. Interest expense of $5,749 was accrued on these advances during the nine months ended May 31, 2016 (2015 - $5,607) and $7,572 during the year ended August 31, 2015 (2014 - $3,310). Accrued interest payable to the President totaled $16,631 at May 31, 2016 (2015 - $8,917) and $10,882 at August 31, 2015 (2014 - $3,310).

 

Consulting fees paid or accrued as payable to a company controlled by the President of the Company were $97,100 and $66,300 for the nine months ended May 31, 2016 and 2015, respectively.

 

Consulting fees accrued as payable to a company controlled by the CFO of the Company were $50,000 and $nil for the nine months ended May 31, 2016 and 2015, respectively.

 

At May 31, 2016, the Company owed $288,945 (2015 - $270,995) to its President, including the above advances and accrued interest and $14,814 (2015 - $9,578) for reimbursable expenses incurred on the Company’s behalf. At August 31, 2015, the Company owed $265,630 (2014 - $262,272) to its President, including the above advances and accrued interest and $2,248 (2014 - $13,962) for reimbursable expenses incurred on the Company’s behalf.

 

At May 31, 2016, the Company owed $175,300 (2015 - $56,100) in consulting fees to a company controlled by the President of the Company. At August 31, 2015, the Company owed $78,200 (2014 - $nil) in consulting fees to a company controlled by the President of the Company.

 

At May 31, 2016, the Company owed $50,000 (2015 - $nil) in consulting fees to a company controlled by the CFO of the Company.

 

All transactions with related parties occurred in the normal course of business and were measured at the exchange amount, which was the amount of consideration agreed upon between management and the related parties.

 

Also see Note 12.

 

F-13
 

 

TROPIC INTERNATIONAL INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(EXPRESSED IN CANADIAN DOLLARS)

(UNAUDITED)

 

10. Advances from Shareholders

 

Shareholders of the Company advanced $nil to the Company during the nine months ended May 31, 2016 (2015 - $95,000) and $95,000 during the year ended August 31, 2015 (2014 - $62,500). Advances payable to shareholders totaled $157,500 at May 31, 2016 (2015 - $157,500) and $157,500 at August 31, 2015 (2014 - $62,500). These advances are unsecured and bear interest at 3% per annum. Of this amount, $12,500 is due on demand and $145,000 has no repayment terms. Interest expense of $3,547 was accrued on these advances during the nine months ended May 31, 2016 (2015 - $2,930) and $4,065 during the year ended August 31, 2015 (2014 - $228). Accrued interest payable to shareholders totaled $7,840 at May 31, 2016 (2015 - $3,158) and $4,293 at August 31, 2015 (2014 - $228).

 

11. Commitments

 

Pursuant to a consulting agreement entered into on November 16, 2015 with Edgewater Consulting Corp. (“ECC”), the Company is required to cause Subco to issue 1,500,000 exchangeable preferred shares to ECC. On the one year anniversary of the agreement, the Company shall cause an additional 1,500,000 exchangeable preferred shares to be issued to ECC. If ECC ceases to be engaged by the Company on the six month anniversary of either date, the issuance of these shares can be automatically rescinded.

 

On February 4, 2016, the Company entered into a consulting agreement with a company (the “Consultant”), whereby the Consultant, through its principal, is to provide to the Company assistance in developing marketing plans, raising capital, and other strategic planning. This agreement runs for three years, with the Company to pay to the Consultant US$10,000 at the agreement date (paid), US$10,000 30 days following the agreement date (paid), and another US$5,000 30 days thereafter (paid), as well as a 10% cash commission on sales facilitated by the Consultant and an 8% cash and warrants commission for the sale of equity securities to investors introduced by the Consultant. If the Consultant raises an aggregate of $2,000,000 in gross proceeds from the sale of equity securities to investors, the Company shall appoint the principal of the Consultant as Company CEO.

 

On February 10, 2016, the Company renewed its premises lease dated November 11, 2011 for one additional year from February 1, 2016 to January 31, 2017 for a rental of $13,200 per year plus HST.

 

12. Stockholders’ Equity

 

The Company is authorized to issue 300,000,000 shares of common stock at a par value of $0.001.

 

At May 31, 2016 and August 31, 2015, the Company had 12,264,146 shares of common stock legally issued and outstanding.

 

On June 28, 2013, pursuant to the Exchange Agreement, RMI acquired 78,030,877 common shares of TSI in exchange for the issuance of 78,030,877 preferred shares of Subco to the Selling Shareholders on a one-for-one basis. As a result of the Exchange Agreement, TSI became the Company’s majority-owned subsidiary. Each preferred share of Subco is exchangeable into one share of the Company’s common stock at the option of the holder subject to certain restrictions. As at May 31, 2016 and August 31, 2015, none of the preferred shares had been exchanged. Accordingly, the number of shares of the Company’s common stock outstanding at May 31, 2016 is equal to the number of shares outstanding immediately prior to the consummation of the Exchange Agreement.

 

As a condition of the closing of the Exchange Agreement, the Company also entered into a Support Agreement and a Voting and Exchange Trust Agreement on the closing date. The Support Agreement ensures that the obligations of Subco remain effective until all of the preferred shares have been exchanged. The Voting and Exchange Trust Agreement provides and establishes a procedure whereby the voting rights attached to shares of the Company’s common stock are exercisable by the registered holders (the Selling Shareholders) of the preferred shares. The Trustee holds legal title to a Special Voting Share to which voting rights are attached for the benefit of the Selling Shareholders. The Trustee holds the Special Voting Share solely for the use and benefit of the Selling Shareholders.

 

F-14
 

 

TROPIC INTERNATIONAL INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(EXPRESSED IN CANADIAN DOLLARS)

(UNAUDITED)

 

12. Stockholders’ Equity (cont’d)

 

Common Stock Issuances

 

During the nine months ended May 31, 2016 and the year ended August 31, 2015, the Company issued no shares.

 

During the nine months ended May 31, 2016, $149,991 (2015 - $15,000) in stock subscriptions were received pursuant to five individual private placements. These subscriptions are for a total of:

 

  160,000 units of the Company at a price of $0.25 per unit. Each unit consists of one share of the Company’s common stock and one warrant to purchase one share of common stock exercisable at a price of $0.40 per share for two years.
     
  322,340 units of the Company at a price of US$0.25 per unit. Each unit consists of one share of the Company’s common stock and one warrant to purchase one share of common stock exercisable at a price of US$0.40 per share for two years.

 

During the year ended August 31, 2015, $30,000 (2014 - $nil) in stock subscriptions were received pursuant to three individual private placements. These subscriptions were for a total of 120,000 units of the Company at a price of $0.25 per unit. Each unit consists of one share of the Company’s common stock and one warrant to purchase one share of common stock exercisable at a price of $0.40 per share for two years.

 

13. Risks and Uncertainties

 

The Company’s future results of operations involve a number of risks and uncertainties. Factors that could affect its future operating results and cause actual results to vary materially from expectations include, but are not limited to: current economic conditions, uncertainty in the potential markets for its Home Mist Tanning units, increasing competition, and dependence on its existing management and key personnel.

 

14. Accounting Pronouncements

 

In June 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-10, which amended Accounting Standards Codification (“ASC”) Topic 915 Development Stage Entities. The amendment eliminates certain financial reporting requirements surrounding development stage entities, including an amendment to the variable interest entities guidance in ASC Topic 810, Consolidation. The amendment removes the definition of a development stage entity from the ASC, thereby removing the financial reporting distinction between development stage entities and other entities from U.S. GAAP. Consequently, the amendment eliminates the requirements for development stage entities to (1) present inception-to-date information in the statements of income, cash flows and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose the first year in which the entity is no longer a development stage entity. This amendment is effective for fiscal years beginning after December 15, 2014, and interim periods therein. The Company adopted this amendment effective September 1, 2015 and, as a result, the Company is no longer presenting or disclosing the information previously required under Topic 915. The adoption of this amendment alters the disclosure requirements of the Company, but it does not have any impact on the Company’s financial position or results of operations for the current or any prior reporting period.

 

F-15
 

 

TROPIC INTERNATIONAL INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(EXPRESSED IN CANADIAN DOLLARS)

(UNAUDITED)

 

14. Accounting Pronouncements (cont’d)

 

In August 2014, the FASB issued ASU No. 2014-15, “Presentation of Financial Statements-Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (“ASU 2014-15”). ASU 2014-15 is intended to define management’s responsibility to evaluate whether there is substantial doubt about an organization’s ability to continue as a going concern and to provide related footnote disclosures. The amendments in this ASU are effective for reporting periods beginning after December 15, 2016, with early adoption permitted. The Company is currently assessing the impact the adoption of ASU 2014-15 will have on its financial statements and related disclosures.

 

In July 2015, the FASB issued ASU No. 2015-11, which amended Accounting Standards Codification (“ASC”) Topic 330 Inventory. The amendment simplifies the measurement of inventory, applying to inventories for which cost is determined by methods other than last-in first-out (LIFO) and the retail inventory method (RIM), specifying that an entity should measure inventory at the lower of cost and net realizable value instead of at the lower of cost or market. The amendments in this ASU are effective for fiscal years beginning after December 15, 2016, and interim periods therein. The Company is currently assessing the impact the adoption of the amendment will have on its financial statements and related disclosures.

 

15. Contingent Liability

 

Pursuant to the Exchange Agreement, as amended, the Company may be required to acquire up to 21,969,123 common shares of TSI, being those TSI shares still outstanding, in exchange for 21,969,123 preferred shares of Subco on a one-for-one basis. Such preferred shares would then be exchangeable on the same basis as the approximately 78 million Subco preferred shares currently outstanding (see Notes 2 and 12).

 

16. Subsequent Event

 

On June 6, 2016, the Company entered into a share exchange agreement with Notox Bioscience Inc. (“Notox”), a private Nevada corporation, and all the shareholders of Notox (the “Notox Shareholders”) pursuant to which the Company agreed to acquire all the issued and outstanding capital stock of Notox from the Notox Shareholders in consideration for the issuance of 100,000,000 restricted shares of Company common stock.

 

The share exchange occurred on June 13, 2016, at which time Notox acquired 100% of the right, title and interest in and to an exclusive license agreement with the Cleveland Clinic Foundation held by Zoran Holding Corporation, a private Ontario corporation, the Company issued the 100,000,000 restricted shares described above to the Notox Shareholders, and Notox became a wholly-owned subsidiary of the Company.

F-16
 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This quarterly report on Form 10-Q (this “Report”) contains forward-looking statements. The forward-looking statements are contained principally in the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section of this Report. These statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “anticipates”, “believes”, “seeks”, “could”, “estimates”, “expects”, “intends”, “may”, “plans”, “potential”, “predicts”, “projects”, “should”, “would” and similar expressions intended to identify forward-looking statements. Forward-looking statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Such statements may include, but are not limited to, information related to: anticipated operating results; relationships with our customers; consumer demand; financial resources and condition; changes in revenues; changes in profitability; changes in accounting treatment; cost of sales; selling, general and administrative expenses; interest expense; the ability to produce the liquidity or enter into agreements to acquire the capital necessary to continue our operations and take advantage of opportunities; legal proceedings and claims.

 

Also, forward-looking statements represent our estimates and assumptions only as of the date of this Report. You should read this Report and the documents that we reference and file or furnish as exhibits to this Report completely and with the understanding that our actual future results may be materially different from what we expect. Except as required by law, we assume no obligation to update any forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in any forward-looking statements, even if new information becomes available in the future.

 

PRESENTATION OF INFORMATION

 

Except as otherwise indicated by the context, references in this Report to “we”, “us” and “our” are to the combined business of Tropic International Inc. and its consolidated subsidiaries.

 

This Report includes our interim unaudited consolidated financial statements as at and for the three and nine months ended May 31, 2016. These financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“US GAAP”). All financial information in this Report is presented in Canadian dollars, unless otherwise indicated, and should be read in conjunction with our interim unaudited consolidated financial statements and the notes thereto included in this Report.

 

As disclosed in our current report on Form 8-K dated July 3, 2013, on June 28, 2013 (the “Closing Date”), we completed a share exchange with Tropic Spa Inc. (“Tropic Spa”), an Ontario corporation, 1894632 Ontario Inc., an Ontario corporation (“Subco”), and certain of the shareholders of Tropic Spa (collectively, the “Tropic Spa Shareholders”), pursuant to which we acquired 78,030,877 common shares, or approximately 78% of the issued and outstanding shares, of Tropic Spa in exchange for the issuance of 78,030,877 preferred shares of Subco, our wholly owned subsidiary, to the Tropic Spa Shareholders on a one-for-one basis (the “Share Exchange”). Each preferred share of Subco is exchangeable into one share of our common stock at the option of the holder thereof, subject to certain restrictions. As a result of the Share Exchange, Tropic Spa became our majority-owned subsidiary and the former shareholders of Tropic Spa became holders of the preferred shares of Subco, a company that has only one issued and outstanding common share which is held by us. The transaction was accounted for as a reverse takeover/recapitalization effected by a share exchange, wherein Tropic Spa is considered the acquirer for accounting and financial reporting purposes. Our consolidated financial statements are therefore, in substance, those of Tropic Spa.

 

 4 
   

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion and analysis of our results of operations and financial condition has been derived from and should be read in conjunction with our interim unaudited consolidated financial statements and the related notes thereto that appear elsewhere in this Report, as well as the “Presentation of Information” section that appears at the beginning of this Report.

 

Overview

 

We are a development stage company in the business of developing and commercializing an innovative home mist tanning system. Our goal is to market a unique system for convenient home use that delivers a full-body application and eliminates the harmful health effects associated with traditional tanning beds. To date, we have finalized the design of our product, applied for and acquired a United States Patent for it entitled “Apparatus for Spray Application of a Sunless Tanning Product” (the “U.S. Patent”) and an Australian patent entitled “Automated mist tanning apparatus” (the “Australian Patent”) and have patents pending which are in the process of being completed for Canada and China. We have also prepared our product for market and completed two phases of test marketing initiatives, and we are currently preparing to launch a comprehensive three-phase marketing strategy.

 

Our home mist tanning system delivers a full-body application in 12 seconds resulting in a tan that develops gradually over a period of five to eight hours and lasts from between five and eight days. The packages we market contain everything an individual needs to complete 10 full-body tans in the comfort of their own home. It consists of an application unit, a tanning kit and a pre-tan kit.

 

On the Closing Date, we completed the Share Exchange whereby we acquired approximately 78% of the issued and outstanding capital stock of Tropic Spa in exchange for 78,030,877 preferred shares of Subco, our wholly owned subsidiary. As a result of the Share Exchange, Tropic Spa became our majority-owned subsidiary, we assumed the business and operations of Tropic Spa and we changed our business address from Toronto, Ontario to Woodstock, Ontario. In order to more accurately reflect our new business operations, on December 6, 2013, we changed our name from “Rockford Minerals Inc.” to “Tropic International Inc.” as a result of a merger with Tropic International Inc., our wholly-owned subsidiary that was incorporated solely to effect the name change.

 

Tropic Spa was incorporated under the laws of the Province Ontario on September 17, 2007. Its operations to date have consisted of business formation, strategic development, test marketing, technology development and capital raising activities. The majority of Tropic Spa’s marketing efforts since its inception have focused on acquiring as much data as possible from its anticipated target markets in order to prepare for the launch of its three-phase marketing strategy described elsewhere in this Report.

 

On June 6, 2016, we entered into a share exchange agreement (the “Share Exchange Agreement”) with Notox Bioscience Inc. (“Notox”), a private Nevada corporation, and all the shareholders of Notox (the “Notox Shareholders”) pursuant to which we agreed to acquire all the issued and outstanding capital stock of Notox from the Notox Shareholders in consideration for the issuance of 100,000,000 restricted shares of our common stock.

 

The closing of the Share Exchange Agreement occurred on June 13, 2016, at which time Notox acquired 100% of the right, title and interest in and to an exclusive license agreement with the Cleveland Clinic Foundation held by Zoran Holding Corporation, a private Ontario corporation, we issued the 100,000,000 restricted shares described above to the Notox Shareholders, and Notox became our wholly owned subsidiary. As a result, we are now a holding company operating through both Tropic Spa and Notox.

 

Results of Operations

 

Revenue

 

During the nine months ended May 31, 2016, we generated $863 in revenue, all of which was in the form of sales revenue, compared to $3,626 during the same period in 2015.

 

Production Costs

 

During the nine months ended May 31, 2016, we incurred production costs of $319,958 which, when subtracted from the revenue we generated during the period, resulted in a gross loss of $319,095. During the nine months ended May 31, 2015, we incurred production costs of $326,136 and a gross loss of $322,510. Our production costs during both periods were relatively consistent and were attributable to a combination of patent amortization ($280,453 in the current period vs. $279,806 in the prior period), production-related consulting fees ($23,400 in both the current period and the prior period), depreciation ($8,015 in the current period vs. $10,019 in the prior period), materials and supplies ($7,725 in the current period vs. $12,382 in the prior period) and writedowns of inventory ($365 in the current period vs. $529 in the prior period).

 

 5 
   

 

Expenses

 

During the nine months ended May 31, 2016, we incurred $398,601 in total expenses, compared to $242,607 during the same period in 2015. All the expenses we incurred during both periods were general and administrative in nature.

 

Our expenses during the nine months ended May 31, 2016 consisted of $283,806 in management-related consulting fees, $56,928 in professional fees, $16,883 in office and miscellaneous expenses, $9,900 in rent, $9,296 in interest on advances from shareholders, $9,250 in travel and entertainment expenses, $8,327 in marketing expenses, $2,122 in trust and filing fees and $2,089 in foreign exchange loss. During the same period in the prior year, our expenses included $138,814 in management-related consulting fees, $39,141 in professional fees, $17,995 in office and miscellaneous expenses, $9,900 in rent, $8,537 in interest on advances from shareholders, $7,349 in travel and entertainment expenses, $12,417 in marketing expenses, $4,123 in foreign exchange loss and $4,331 in depreciation. Apart from the $144,992 and $17,787 increases in our management-related consulting fees and professional fees, respectively, which were primarily attributable to consulting fees accrued to a company controlled by our new Chief Financial Officer and the general increase in our operations during the current period, our expenses were relatively consistent from period to period.

 

During the nine months ended May 31, 2016, we also recorded a $6,794 writedown of patent costs.

 

Net Loss

 

During the nine months ended May 31, 2016, we incurred a net loss and comprehensive loss of $724,490 and a net loss per share of $0.06. During the same period in the prior year, we experienced a net loss and comprehensive loss of $565,117 and a net loss per share of $0.05.

 

Liquidity and Capital Resources

 

As of May 31, 2016, we had $25,982 in cash, $163,644 in current assets, $4,055,330 in total assets, $1,026,170 in current and total liabilities and a working capital deficiency of $862,526. As of that date, we also had an accumulated deficit of $5,595,171.

 

During the nine months ended May 31, 2016, we spent $125,602 in cash on operating activities, compared to $118,732 in cash spending on operating activities during the same period in the prior year. The increase of approximately 6% in our cash spending on operating activities between the two periods was primarily attributable to the increase in our net loss as described above, as adjusted for certain changes in our assets and liabilities, and in particular a substantial increase in our accounts payable and accrued liabilities.

 

We spent $11,743 in cash on investing activities during the nine months ended May 31, 2016, compared to cash spending of $6,037 on investing activities during the same period in the prior year. In each case, all of our spending was associated with patent costs.

 

During the nine months ended May 31, 2016, we received $154,991 in cash from financing activities, compared to receiving $117,500 in cash from financing activities during the same period in the prior year. Substantially all of the cash we received from financing activities during the current period was in the form of stock subscriptions received, whereas substantially all the cash we received during the prior period was in the form of advances from shareholders.

 

 6 
   

 

During the nine months ended May 31, 2016, our cash increased by $17,646 due to a combination of our operating, investing and financing activities.

 

Plan of Operations

 

Our plan of operations for Tropic over the next 12 months is to carry out our three-phase marketing strategy and continue to develop our business, and we anticipate that we will require a minimum of $1,629,200 to pursue those plans, as follows:

 

Description 

Amount

($)

 
Marketing expenses   600,000 
Production costs   450,000 
Professional fees   150,000 
Management-related consulting fees   290,000 
Rent (including utilities)   19,200 
Travel and entertainment expenses   40,000 
Office and miscellaneous expenses   80,000 
Total   1,629,200 

 

We intend to allocate the bulk of our proposed marketing expenses to producing and airing a new infomercial, and we expect interest in our home mist tanning system to increase as a result. Such an increase will likely be accompanied by an increase in sales, which will require us to manufacture additional units and incur substantial production costs. The other expenses we anticipate occurring over the next 12 months are reasonably consistent with those from prior periods.

 

We have not yet developed a detailed plan of operations for Notox yet, but anticipate doing so once we have successfully completed one or more financings. 

 

We do not currently have sufficient funds to carry out our entire plan of operations, so we intend to meet the balance of our cash requirements for the next 12 months through a combination of debt financing and equity financing through private placements. Currently we are active in contacting broker/dealers in Canada and elsewhere regarding possible financing arrangements; however, we do not currently have any arrangements in place to complete any private placement financings and there is no assurance that we will be successful in completing any such financings. If we are unsuccessful in obtaining sufficient funds through our capital raising efforts, we may review other financing options, although we cannot provide any assurance that any such options will be available to us or on terms reasonably acceptable to us. Further, if we are unable to secure any additional financing then we plan to reduce the amount that we spend on our operations, including our management-related consulting fees and other general expenses, so as not to exceed the capital resources available to us. Regardless, our current cash reserves and working capital will not be sufficient to enable us to sustain our business for the next 12 months, even if we do decide to scale back our operations.

 

 7 
   

 

Critical Accounting Policies

 

Inventory

 

Inventory is stated at the lower of cost, computed using the first-in, first-out method, or market. If the cost of inventory exceeds its market value, a provision is made currently for the difference between the cost and market value. Our inventory consists of finished goods, components and supplies.

 

Equipment, Net

 

Equipment is stated at cost, net of accumulated depreciation. Equipment is depreciated over the estimated useful life of the asset. Mould equipment is depreciated at 20% on a declining-balance basis. The website is depreciated on a straight-line basis over five years. One-half of these rates are used in the year of acquisition. Replacements and major improvements are capitalized, while maintenance and repairs are charged to expense as incurred. Upon retirement or sale, the cost of assets disposed of and related accumulated depreciation are removed from the accounts, and any resulting gain or loss is credited or charged to operations.

 

Intangible Assets

 

The U.S. Patent is recorded at the value attributed to the shares issued to the Originating Companies and shareholders of TGSI less accumulated amortization. The U.S. Patent was issued on September 29, 2009 and is effective until September 29, 2026. The Australian Patent is recorded at the application costs incurred less accumulated amortization. The Australian Patent was issued on October 16, 2014 and is effective until April 5, 2027. Upon expiration, the patents can be extended subject to certain changes required to secure the extension. Although the effects of obsolescence, demand, competition and other economic factors (such as stability of the industry, technological advances and legislative action that results in an uncertain or changing regulatory environment) can have an adverse effect on the industry and our product, management is not currently aware of any known adverse factors that will affect us in the future.

 

Costs incurred for patents which are in the process of being completed will be amortized over the life of the patent when the patent is issued.

 

We do not believe that there are any limits to how long our Home Mist Tanning units can sell in the market place. While we expect to be able to secure extensions for our patents prior to expiry, this cannot be predicted with certainty at this time. Accordingly, management has determined that the best estimate of the useful life of the U.S. Patent is 17 years and the Australian Patent is 13 years. At this time, we do not believe that the patents will have a residual value at the end of their useful lives.

 

Definite-lived intangible assets are required to be amortized using a method that reflects the pattern in which the economic benefits of the patents are consumed or utilized. At this time, management is not able to determine with any amount of certainty the number of Home Mist Tanning units that will be sold over the useful life of the patents. Accordingly, the patents are being amortized on a straight-line basis over the period of their useful lives.

 

Intangible assets subject to amortization are required to be reviewed for impairment. An impairment loss must be recognized if the intangible asset’s carrying amount is not recoverable and the carrying amount exceeds fair value. We apply the following three-step process to identify, recognize and measure impairment of the patents:

 

  Consider whether indicators of impairment are present indicating that the patent’s carrying amount might not be recoverable;
     
  If indicators are present, perform a recoverability test by comparing the sum of the estimated undiscounted future cash flows attributable to the patent to its carrying amount; and
     
  If the undiscounted cash flows used in the recoverability test are less than the patent’s carrying amount, determine the patent’s fair value and recognize an impairment loss if the carrying amount exceeds fair value.

 

Because of the unique nature of a patent, an income-producing definite-lived intangible asset, the calculation of cash flows can be very difficult to estimate. In this case, the estimated cash flows reflect the direct revenue expected to be generated by the patent as well as an allocation of expenses.

 

 8 
   

 

Sales, Other Revenue and Deferred Revenue

 

We sell Home Mist Tanning units and related supplies primarily on line via our website. We recognize revenue when the units and supplies have been shipped to the customer, the amount to be paid by the customer is fixed or determinable and collectability is reasonably assured. Revenue is recorded net of applicable sales taxes.

 

In February 2012, we entered into an agreement with a fitness company to insert into every Home Mist Tanning unit package shipped in Canada a brochure advertising their store locations in Canada along with other related information about their fitness stores. Pursuant to this two-year agreement, commencing March 1, 2012 and ending February 28, 2014, we have received $50,000 for this service. Revenue was recognized on a straight-line basis over the term of the agreement.

 

Warranty

 

We are committed to supplying products of superior quality and design. Because of this commitment, we provide a limited one year warranty effective from the date of purchase. We warranty our Home Mist Tanning units to be free of defects. If a unit stops operating due to defects in materials or workmanship, we either repair or replace it for free.

 

Off-Balance Sheet Arrangements

 

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

 

Going Concern

 

Our financial statements have been prepared on a going concern basis, which implies we will continue to realize our assets and discharge our liabilities in the normal course of business. As at May 31, 2016, we had a working capital deficiency of $862,526 and an accumulated deficit of $5,595,171. Our continuation as a going concern is dependent upon the continued financial support from our stockholders, our ability to obtain necessary equity financing to continue operations, and the attainment of profitable operations. These factors raise substantial doubt regarding our ability to continue as a going concern. Our financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

Not required.

 

Item 4. Controls and Procedures

 

Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures, as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”), that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure.

 

 9 
   

 

As of the end of the period covered by this Report, management, with the participation of our Chief Executive and Chief Financial Officer, carried out an evaluation of the effectiveness of our disclosure controls and procedures. Based upon this evaluation, management concluded that our disclosure controls and procedures were not effective due to certain deficiencies in our internal control over financial reporting. These deficiencies include the fact that we have no audit committee, traditionally have had no independent directors, and do not have a system in place to review and monitor internal control over financial reporting.

 

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting such that a reasonable possibility exists that a material misstatement of our financial statements will not be prevented or detected on a timely basis. The deficiencies described above constitute, both individually and in the aggregate, a material weakness given their potential impact on our financial reporting and internal control over financial reporting.

 

Management is currently evaluating remediation plans for the deficiencies and will implement changes as time and financial resources allow.

 

Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act) during the period ended May 31, 2016 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 10 
   

 

PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings

 

We are currently not involved in any litigation that we believe could have a materially adverse effect on our financial condition or results of operations. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of our executive officers or any of our subsidiaries, threatened against or affecting us, our common stock, any of our subsidiaries or our officers or directors of those of our subsidiaries’ in their capacities as such, in which an adverse decision could have a material adverse effect.

 

Item 1A. Risk Factors

 

Not applicable.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

On July 14, 2016, the holders of a majority of our issued and outstanding common stock on a fully converted basis approved a 1 for 2 reverse split of our common stock (the “Reverse Split”) with an anticipated record date of July 26, 2016. As a result of the Reverse Split, our issued and outstanding common stock is expected to decrease from 112,264,146 shares to approximately 56,132,073 shares, with each fractional share being rounded up to the nearest whole share.

 

In order for the Reverse Split to be recognized on the OTCBB and OTCQB, the Financial Industry Regulatory Authority (“FINRA”) will need to process the corporate action. We are in the process of submitting the required documentation to FINRA, but will continue to trade under the symbol “TRPO” until such time as FINRA has declared the Reverse Split effective. Once FINRA has processed the corporate action, we plan to file a current report on Form 8-K to announce the effective date of the Reverse Split as well as our new temporary trading symbol, if applicable.

 

Item 6. Exhibits

 

The following documents are filed as a part of this Report:

 

Exhibit

Number

  Exhibit Description
     
3(i).1   Articles of Incorporation filed with the Nevada Secretary of State on October 29, 2007 (1)
     
3(i).2   Certificate of Amendment filed with the Nevada Secretary of State on August 24, 2010 (1)
     
3(i).3   Certificate of Amendment filed with the Nevada Secretary of State on April 17, 2013 (2)
     
3(i).4   Articles of Merger filed with the Nevada Secretary of State on December 6, 2013 (3)
     
3(ii).1   By-Laws (1)
     
10.1   Share Exchange Agreement dated June 28, 2013 with 1894632 Ontario Inc., Tropic Spa Inc. and the shareholders of Tropic Spa Inc. (4)
     
10.2   Amendment to Share Exchange Agreement dated February 17, 2015 with 1894632 Ontario Inc., Tropic Spa Inc. and the shareholders of Tropic Spa Inc. (5)
     
10.3   Share Exchange Agreement dated June 6, 2016 with Notox Bioscience Inc. and the shareholders of Notox Bioscience Inc. (6)

 

11 
 

 

21   1894631 Ontario Inc. (Ontario, Canada), 1894632 Ontario Inc. (Ontario, Canada), Tropic Spa Inc. (Ontario, Canada)
     
31.1   Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
31.2   Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
32.1   Certification of the Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
32.2   Certification of the Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

(1) Incorporated by reference from our registration statement on Form 10, filed with the SEC on October 15, 2010.
   
(2) Incorporated by reference from our quarterly report on Form 10-Q, filed with the SEC on June 20, 2013.
   
(3) Incorporated by reference from our annual report on Form 10-K, filed with the SEC on December 9, 2013.
   
(4) Incorporated by reference from our current report on Form 8-K, filed with the SEC on July 3, 2013.
   
(5) Incorporated by reference from our current report on Form 8-K, filed with the SEC on February 19, 2015.
   
(6) Incorporated by reference from our current report on Form 8-K, filed with the SEC on June 13, 2016.

 

12 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Dated: July 15, 2016 TROPIC INTERNATIONAL INC.
     
  By: /s/ John Marmora
    John Marmora
    President, Secretary, Treasurer, Director

 

13